Adenocarcinoma of the urinary bladder arising from the
|
|
- Henry Byrd
- 5 years ago
- Views:
Transcription
1 Resident Short Reviews Adenocarcinoma of the Urinary Bladder N Primary adenocarcinoma of urinary bladder is an uncommon neoplasm and is a source of diagnostic confusion with adenocarcinomas arising in adjacent organs, especially colon. These tumors show varied histologic picture and degree of differentiation. Clinical association with bladder exstrophy and schistosomiasis has been well documented. Primary bladder adenocarcinomas have overlapping histologic and immunohistochemical features with adenocarcinomas arising from other primary sites and the suggested immunohistochemical panel includes cytokeratins 7 and 20, 34bE12, thrombomodulin, CDX2, and b-catenin. Clinical, imaging, histologic, and immunohistochemical correlation should be done while rendering this diagnosis, as prognosis and therapeutic options for primary versus metastatic adenocarcinoma vary widely. (Arch Pathol Lab Med. 2011;135: ; doi: /arpa RS) Adenocarcinoma of the urinary bladder arising from the urothelial lining is an uncommon malignant neoplasm, accounting for 0.5% to 2.0% of all malignant vesical tumors. 1 The histologic variants show a predominant colonic (enteric) type glandular morphology with varied histologic patterns. Based on the morphology they are classified as follows: colonic (enteric) type, adenocarcinoma not otherwise specified, mucinous, signet ring cell (SRC), clear cell type, hepatoid, and mixed forms. 2,3 These tumors are also grouped as urachal and nonurachal type, the latter being the focus of this review. Irrespective of the various histologic patterns, there is usually evidence of cystitis cystica et glandularis or surface glandular metaplasia in the adjacent benign urothelium. 2 Recent molecular studies using quantitative fluorescence in situ hybridization hypothesize that intestinal metaplasia in the bladder could be a precursor lesion for vesical adenocarcinoma. 4,5 CLINICAL FEATURES Patients are usually in their sixth decade of life with a male predilection. The most common clinical presentation is hematuria. 6 Bladder irritation symptoms are also frequently reported. 1 About 90% of the tumors arising in Accepted for publication December 27, From the Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. The authors have no relevant financial interest in the products or companies described in this article. Reprints: Somak Roy, MD, Department of Pathology, University of Pittsburgh Medical Center, A615, Scaife Hall, 3550 Terrace St, Pittsburgh, PA ( roys911@gmail.com). Somak Roy, MD; Anil V. Parwani, MD, PhD exstrophied bladder are adenocarcinomas. 2 They are also more prevalent in settings of vesical schistostomiasis. 7,8 Adenocarcinomas can arise anywhere in the urinary bladder. However, they involve the trigone and posterior bladder wall in most cases. 2 About two-thirds of the adenocarcinomas present as solitary, discrete lesions, unlike the usual urothelial carcinomas, which tend to be multifocal. 2,9 GROSS AND MICROSCOPIC PATHOLOGY Adenocarcinomas can have a papillary, nodular, flat, or ulcerated architecture. Some of the adenocarcinoma variants (SRC) tend to present with prominent bladder wall thickening ( linitis plastica like) without apparent growth due to diffuse infiltration of the bladder wall by tumor cells. 2,10 Microscopically, these tumors show pure glandular morphology. Usually they show well to moderately differentiated colonic-type infiltrating glands with or without abundant extracellular mucin (Figure 1). However, in some cases, highly cellular and poorly differentiated morphology may be seen in the absence of the more common colonic glandular histology. 2 The not otherwise specified type shows nonspecific glandular growth pattern. Foci of cystitis cystica may also be seen in some of these tumors (Figure 2). The SRC variant of bladder adenocarcinoma is an aggressive, poorly differentiated rare subtype. This entity is defined as a tumor composed entirely of SRCs or as a poorly differentiated round cell tumor with intracytoplasmic mucin without extracellular mucin. 2,10 12 This variant resembles mammary lobular carcinoma with the exception of large cell size. A dense layer of cells in the lamina propria with diffuse infiltration into the muscularis is commonly seen. The tumors tend to be aggressive with propensity for extravesical soft tissue extension at the time of presentation (higher stage). 2,10 12 This variant can bear morphologic resemblance to plasmacytoid urothelial carcinoma, an unusual bladder tumor 13,14 that is characterized by large cells with abundant eosinophilic cytoplasm and eccentrically placed vesicular nucleus with prominent nucleolus, closely resembling a plasma cell. 13,14 Signet ring cell variant, in contrast, has cells with a clear cytoplasmic vacuole and an indented eccentrically placed nucleus. The plasmacytoid urothelial carcinomas are poorly differentiated high-grade tumors and often have a coexisting high-grade conventional urothelial carcinoma or a sarcomatoid carcinoma component. 14 This is, however, an uncommon finding in SRC variant. The mucinous (colloid) variant displays abundant pools of extracellular mucin with groups of tumor cells floating Arch Pathol Lab Med Vol 135, December 2011 Vesical Adenocarcinoma Roy & Parwani 1601
2 Figure 1. Adenocarcinoma of bladder, enteric type. Invasive small- to medium-sized well-formed glands with luminal dirty necrosis and focal cribriform pattern. Stroma is desmoplastic and edematous. Histologic features are indistinguishable from colonic adenocarcinoma (hematoxylineosin, original magnification 3100). Figure 2. Adenocarcinoma of bladder, enteric type (transurethral resection specimen) showing fragment of urothelium-lined tissue with cystitis cystica (hematoxylin-eosin, original magnification 3200). Figure 3. Invasive adenocarcinoma of bladder, mucinous type. Extensive extracellular pools of mucin with malignant glands and cells floating on it. Right lower field shows benign reactive urothelium (hematoxylin-eosin, original magnification 340). Figure 4. Invasive adenocarcinoma of bladder, mucinous type. Occasional signet ring cells in pool of mucin. This, however, does not qualify for diagnosis of signet ring cell adenocarcinoma (hematoxylin-eosin, original magnification 3100). on it.2,3,15 This variant is usually well differentiated and mimics many extravesical mucinous tumors histologically (Figure 3). They may show SRCs with intracellular mucin (Figure 4); however, they do not qualify to be classified as SRC variant by the definition stated previously. The grading system of bladder adenocarcinomas is based on the degree of glandular differentiation and nuclear pleomorphism (well, moderate, and poorly differentiated).3 DIFFERENTIAL DIAGNOSIS AND IMMUNOHISTOCHEMISTRY Bladder adenocarcinoma needs to be distinguished from the more common metastatic adenocarcinoma (direct spread, lymphatic, and hematogenous). The principal primary organs to be considered include prostate, colon, female genital tract, appendix, stomach, and breast.2,15, Arch Pathol Lab Med Vol 135, December 2011 The evidence supporting the fact that the entity represents a primary vesical adenocarcinoma is the presence of flat carcinoma in situ. The latter is difficult to document, particularly in transurethral resection specimens due to extensive thermal artefact, incomplete sampling, and presence of mucosal ulcerations.2 Also, secondary adenocarcinomas tend to colonize the native epithelium mimicking a carcinoma in situ component. The most frequent and challenging differential diagnosis remains metastatic or directly spreading colonic adenocarcinoma. The latter is virtually indistinguishable on histomorphology as well as on immunohistochemistry.2,3,15,17,18 Differential diagnosis is even more difficult on small biopsies with poorly differentiated tumors. The extreme similarity of vesical and colonic adenocarcinomas has raised the interesting, though controversial, proposition of the pathogenic relationship of these tumors. It is hypothesized that due to the common Vesical Adenocarcinoma Roy & Parwani
3 Figure 5. A, Adenocarcinoma of bladder. Tumor cells show focal strong positivity for cytokeratin 20. B, Adenocarcinoma of bladder. Tumor cells demonstrating weak immunoexpression of thrombomodulin. C, Adenocarcinoma of bladder; strong diffuse nuclear expression of CDX2. D, Adenocarcinoma of bladder; membranous staining pattern of b-catenin (original magnification 3200 [A]; original magnification 3400 [B]; original magnification 3100 [C]; original magnification 3400 [D]). embryologic origin of the bladder and the rectum from the cloaca, vesical adenocarcinomas may arise from pluripotent cloacal cells that undergo similar genetic changes as seen in colonic adenocarcinomas.15 The immunohistochemical panel used to distinguish primary vesical adenocarcinoma from metastatic colonic adenocarcinoma includes cytokeratin (CK) 7, CK20, 34bE12, thrombomodulin, villin, CDX-2, and b-catenin.3,15 21 CK7 and CK20 are reported to be positive in more than half of primary bladder adenocarcinomas (Figure 5, A).15,16,21 The typical colonic adenocarcinoma staining profile, CK7 negative and CK20 positive, has been reported in 29% of primary vesical adenocarcinomas.15 A combination of CK7 and CK20 by itself does not appear to differentiate primary bladder from colonic adenocarcinomas. Thrombomodulin, an endothelial thrombin receptor, is a sensitive urothelial marker. Wang et al15 reported 90% expression of thrombomodulin in urothelial carcinoma. However, only 59% of the bladder adenocarcinomas and none of the colonic adenocarcinomas were positive for this marker (Figure 5, B). Arch Pathol Lab Med Vol 135, December 2011 CDX-2 is a homeobox gene implicated in regulation of growth and differentiation of intestinal epithelial cells. It acts as a nuclear transcription factor and therefore demonstrates nuclear staining in normal colonic epithelial cells and colonic adenocarcinoma.15,19 Its expression was initially thought to be restricted to colonic adenocarcinomas. However, recent studies have shown the immunoexpression of CDX-2 in vesical adenocarcinomas as well (Figure 5, C).19 This overlapping immunophenotype diminishes the utility of CDX-2 in the differential diagnosis between the 2 entities. b-catenin is a key component of the cadherin-mediated cell-cell adhesion system and is abnormally accumulated in the nucleus of tumor cells (colorectal adenocarcinomas) due to impaired adenomatous polyposis coli b-catenin interaction. Wang et al15 found consistent nuclear expression of b-catenin in 81% of colonic adenocarcinomas metastatic to the bladder. Nuclear pattern of staining was restricted to this group of tumors. Membranous staining pattern was observed in 88% of primary vesical adenocarcinomas and in all cases of colorectal adenocarcinomas (Figure 5, D). It was concluded that the b-catenin Vesical Adenocarcinoma Roy & Parwani 1603
4 dysregulation mechanism is not functional in bladder adenocarcinomas and also that nuclear versus membranous staining pattern is a good marker for distinction between these 2 tumor entities. Thomas et al 22 studied b- catenin expression in conjunction with E-cadherin expression in SRC primary bladder adenocarcinoma. They demonstrated membranous staining of b-catenin in all foci of colonic-type adenocarcinoma and 78% of the SRC foci. The study concluded that the decreased expression of both markers in SRC foci might be attributed to alteration in the signaling pathway. Sordo et al 11 demonstrated only membranous expression in all cases of SRC adenocarcinoma. No nuclear staining was observed. Gopalan et al 21 in their study of urachal adenocarcinomas demonstrated 93% of cases with membranous expression of b-catenin with focal nuclear staining in 1 of the cases. They concluded that the presence of predominant nuclear expression of b-catenin would not be compatible with primary urachal adenocarcinoma. 34bE12, a high-molecular-weight cytokeratin, is a sensitive and relatively specific marker for basal cells of prostatic acini. It demonstrates strong cytoplasmic staining in these cells. Gopalan et al 21 reported 66% and 11% positivity of 34bE12 in urachal and colonic adenocarcinomas, respectively. They concluded that a strong diffuse positivity would favor urachal over colonic adenocarcinoma. Urachal carcinoma is a less common tumor that can present as a bladder mass and should be considered in the list of differential diagnoses. 3,21 This tumor tends to occur in the dome and anterior bladder wall and usually has a male predominance. 21 Adenocarcinoma with enteric features is the most common histologic subtype and can also show mucinous and SRC variants. 3,21 Diagnostic criteria for urachal carcinoma include (1) tumor in the dome; (2) absence of cystitis cystica and cystitis glandularis; (3) predominant invasion of the muscularis or deeper tissues with a sharp demarcation between the tumor and surface bladder urothelium that is free of glandular or polypoid proliferation; (4) urachal remnants within the tumor; (5) extension into the bladder wall with involvement of the space of Retzius, anterior abdominal wall, or umbilicus; and (6) no evidence of a primary neoplasm elsewhere. 23 The previous criteria help in differentiating it from primary vesical adenocarcinomas. Immunohistochemical profile is similar to primary vesical adenocarcinoma and hence is of no practical utility. 21 The management of urachal carcinoma is typically a partial cystectomy as opposed to a radical cystectomy for primary bladder adenocarcinomas. Prostatic adenocarcinomas often directly extend into the bladder and may coexist with a bladder adenocarcinoma. The most reliable immunohistochemical marker is prostate-specific antigen, which stains approximately 90% of poorly differentiated prostatic adenocarcinomas and is negative in bladder adenocarcinomas. 3,16 CA 125, which stains the tumor cells of endometrial and ovarian malignancies, has been reported to be of use to differentiate endometrial and ovarian carcinoma from primary bladder adenocarcinomas. 16 Vimentin highlights endometrial carcinoma cells as opposed to bladder adenocarcinoma cells. 3 Metastatic breast carcinoma may be differentiated from SRC vesical carcinoma using estrogen receptor and gross cystic disease fluid protein 15, which stain breast carcinoma cells. 11 OTHER VARIANTS OF VESICAL ADENOCARCINOMA Clear Cell Adenocarcinoma Clear cell adenocarcinoma is an unusual and rare variant of bladder adenocarcinoma with a particularly strong predilection for females, with a reported mean age of 57 years. 24,25 Gross hematuria, dysuria, suprapubic pain, and discharge are the usual presenting symptoms. Clear cell adenocarcinoma is histologically and ultrastructurally similar to clear cell tumors of the female genital tract of possible müllerian origin. 2,3,25,26 The tumor has an exophytic, polypoidal, or papillary appearance and usually involves the posterior and lateral walls or the trigone. 3,24 Histology is characterized by varied architectural patterns of tubulocystic to papillary or diffuse sheets of cells. The tumor cells range from flat, cuboidal to columnar cells with eosinophilic to clear cytoplasm, often containing glycogen. They occasionally demonstrate prominent hobnailing. There is moderate to severe nuclear atypia with frequent mitosis. Associated histologic features include concurrent presence of urothelial carcinoma, adenocarcinoma not otherwise specified type, cystitis cystica glandularis, and prominent inflammatory infiltrate. 3,24,25 Immunohistochemically, the tumor cells are positive for CA ,25,27 The tumor cells also express pancytokeratin, CK7, and CK20 (variable). 23,25,27 The tumor cells variably express S100 protein, carcinoembryonic antigen, Leu-M1, and CA 19.9 and are consistently negative for prostatespecific antigen and prostatic acid phosphatase. 25,27 Nephrogenic adenoma is the most important differential diagnosis. Both entities have overlapping morphologic and immunohistochemical profiles. However, clear cell adenocarcinomas demonstrate pronounced nuclear atypia and numerous mitoses. A higher MIB-1 index and a stronger p53 staining have been reported in clear cell adenocarcinomas unlike in nephrogenic adenomas. 27 Urothelial carcinomas can occasionally display abundant glycogen-rich clear cells and lack the other histologic features of clear cell adenocarcinoma. 25 Other lesions that need to be distinguished from clear cell adenocarcinoma include vaginal or cervical clear cell carcinomas, clear cell prostatic adenocarcinoma, and metastatic clear cell renal cell carcinoma. Overall, these entities are rare and clinicoradiologic correlations with immunohistochemistry are helpful in arriving at the correct diagnosis. 3,25 Hepatoid Adenocarcinoma Hepatoid adenocarcinoma is an extremely rare tumor of the bladder, described in very few case reports. 28 Clinically, this is an aggressive tumor primarily affecting elderly men. Diagnosis is based on morphologic resemblance to hepatocellular carcinoma and positive immunostaining for a-fetoprotein. The tumor cells are large and polygonal with abundant granular eosinophilic cytoplasm and vesicular nuclei with prominent nucleoli. The cells are arranged in a trabecular pattern. Hyaline globules and bile production can also be seen. Hepatocellular differentiation can be documented by expression of a-fetoprotein, a 1 -antitrypsin, albumin, HepPar-1, epithelial membrane antigen, and carcinoembryonic antigen. 28 THERAPY AND PROGNOSIS The main stay of treatment is surgery with or without adjuvant radiation or chemotherapy. Radical or partial 1604 Arch Pathol Lab Med Vol 135, December 2011 Vesical Adenocarcinoma Roy & Parwani
5 cystectomy with or without node dissection is the commonly used surgical procedure. 1 The most important prognostic factor is tumor stage. 1 Histologic subtypes especially SRC and clear cell variants behave more aggressively. CONCLUSION Primary adenocarcinoma of the bladder is an uncommon neoplasm with a spectrum of histomorphologic appearances. The more common metastatic adenocarcinomas, especially colonic, need to be ruled out before making a diagnosis of primary vesical adenocarcinoma. Because histologically and immunohistochemically there is considerable overlap between colonic and vesical adenocarcinoma, extensive clinical and radiologic workup is required for diagnostic accuracy. The panel of markers required for primary versus secondary adenocarcinomas should be carefully selected based on the morphology of the tumor and its related entities in the differential diagnosis. Although the immunomarkers discussed previously do not individually prove to be diagnostically significant, a panel of stains is helpful such as a combination of CK7, CK20, thrombomodulin, b-catenin, 34bE12, and prostate-specific antigen. References 1. Grignon DJ, Ro JY, Ayala AG, Johnson DE, Ordóñez NG. Primary adenocarcinoma of the urinary bladder: a clinicopathologic analysis of 72 cases. Cancer. 1991;67(8): Epstein JI, Amin MB, Reuter VE. Glandular lesions. In: Epstein JI, Amin MB, Reuter VE, eds. Bladder Biopsy Interpretation: Biopsy Interpretation Series. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2010: Bostwick DG, Cheng L. Neoplasms of the urinary bladder. In: Bostwick DG, Cheng L. Urologic Surgical Pathology. 2nd ed. Philadelphia, PA: Mosby; 2008: Morton MJ, Zhang S, Lopez-Beltran A, et al. Telomere shortening and chromosomal abnormalities in intestinal metaplasia of the urinary bladder. Clin Cancer Res. 2007;13(20): Sung MT, Lopez-Beltran A, Eble JN, et al. Divergent pathway of intestinal metaplasia and cystitis glandularis of the urinary bladder. Mod Pathol. 2006; 19(11): Bollito ER, Pacchioni D, Lopez-Beltran A, et al. Immunohistochemical study of neuroendocrine differentiation in primary glandular lesions and tumor of urinary bladder. Anal Quant Cytol Histol. 2005;27(4): Shaaban AA, Elbaz MA, Tribukait B. Primary non-urachal adenocarcinoma in the bilharzial urinary bladder: deoxyribonucleic acid flow cytometric and morphologic characterization of 93 cases. Urology. 1998;51(13): El-Merkresh MM, El-Baz MA, Abol-Enein H, Ghoneim MA. Primary adenocarcinoma of urinary bladder: a report of 185 cases. Br J Urol. 1998; 82(2): Melicow MM. Tumor of the urinary bladder: a clinicopathological analysis of over 2500 specimens and autopsies. J Urol. 1955;74(4): Poore TE, Egbert B, Jahnke R, Kraft JK. Signet ring cell adenocarcinoma of the bladder: linitis plastic variant. Arch Pathol Lab Med. 1981;105(4): Sordo RD, Bellezza G, Colella R, Mameli MG, Sidoni A, Cavaliere A. Primary signet-ring cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 5 cases. Appl Immunohistochem Mol Morphol. 2009;17(1): Grignon DJ, Ro JY, Ayala AG, Johnson DE. Primary signet-ring cell carcinoma of the urinary bladder. Am J Clin Pathol. 1991;95(1): Gaafar A, Garmendia M, de Miguel E, et al. Plasmacytoid urothelial carcinoma of the urinary bladder: a study of 7 cases. Actas Urol Esp. 2008;32(8): Amin MB. Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications. Mod Pathol. 2009;22(suppl 2):S96 S Wang HL, Lu DW, Yerian LM, et al. Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Am J Surg Pathol. 2001;25(11): Torenbeek R, Lagendijk JH, Van Diest PJ, Bril H, van de Molengraft FJ, Meijer CJ. Value of a panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma. Histopathology. 1998;32(1): Suh1 N, Yang XJ, Tretiakova MS, Humphrey PA, Wang HL. Value of CDX2, villin, and a-methylacyl coenzyme A racemase immunostains in the distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Mod Pathol. 2005;18(9): Raspollini MR, Nesi G, Baroni G, Girardi LR, Taddei GL. Immunohistochemistry in the differential diagnosis between primary and secondary intestinal adenocarcinoma of the urinary bladder. Appl Immunohistochem Mol Morphol. 2005;13(4): Werling RW, Yaziji H, Bacchi CE, Gown AM. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin and immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol. 2003;27(3): Tamboli P, Mohsin SK, Hailemariam S, Amin MB. Colonic adenocarcinoma metastatic to the urinary tract versus primary tumors of the urinary tract with glandular differentiation: a report of 7 cases and investigation using a limited immunohistochemical panel. Arch Pathol Lab Med. 2002;126(9): Gopalan A, Sharp DA, Fine SW, et al. Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation. Am J Surg Pathol. 2009; 33(5): Thomas AA, Stephenson AJ, Campbell SC, Jones JS, Hansel DE. Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder. Hum Pathol. 2009;40(1): Sheldon CA, Clayman RV, Gonzalez R, Williams RD, Fraley EE. Malignant urachal lesions. J Urol. 1984;131(1): Oliva E, Amin MB, Jimenez R, Young RH. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems. Am J Surg Pathol. 2002;26(2): Adeniran AJ, Tamboli P. Clear cell adenocarcinoma of the urinary bladder: a short review. Arch Pathol Lab Med. 2009;133(6): Peven DR, Hidvegi DF. Clear-cell adenocarcinoma of the female urethra. Acta Cytol. 1985;29(2): Gilcrease MZ, Delgado R, Vuitch F, Albores-Saavedra J. Clear cell adenocarcinoma and nephrogenic adenoma of the urethra and urinary bladder: a histopathologic and immunohistochemical comparison. Hum Pathol. 1998; 29(12): Lopez-Beltran A, Luque RJ, Quintero A, Requena MJ, Montironi R. Hepatoid adenocarcinoma of the urinary bladder. Virchows Arch. 2003;442(4): Arch Pathol Lab Med Vol 135, December 2011 Vesical Adenocarcinoma Roy & Parwani 1605
J of Evolution of Med and Dent Sci/ eissn , pissn / Vol. 3/ Issue 24/June 16, 2014 Page 6628
ADENOCARCINOMA OF BLADDER-SIGNET RING CELL MUCINOUS VARIANT S. Senthil Kumar 1, D. Prem Charles 2, B. Krishnaswamy 3, P. Viswanathan 4, S. Sarath Chandran 5 HOW TO CITE THIS ARTICLE: S. Senthil Kumar,
More informationSynonyms. Nephrogenic metaplasia Mesonephric adenoma
Nephrogenic Adenoma Synonyms Nephrogenic metaplasia Mesonephric adenoma Definition Benign epithelial lesion of urinary tract with tubular, glandular, papillary growth pattern Most frequently in the urinary
More information5/21/2018. Prostate Adenocarcinoma vs. Urothelial Carcinoma. Common Differential Diagnoses in Urological Pathology. Jonathan I.
Common Differential Diagnoses in Urological Pathology Jonathan I. Epstein Prostate Adenocarcinoma vs. Urothelial Carcinoma 1 2 NKX3.1 NKX3.1 3 4 5 6 Proposed ISUP Recommendations Option to use PSA as a
More informationUrinary Bladder: WHO Classification and AJCC Staging Update 2017
Urinary Bladder: WHO Classification and AJCC Staging Update 2017 Houston Society of Clinical Pathologists 58 th Annual Spring Symposium Houston, TX April 8, 2017 Jesse K. McKenney, MD Classification
More informationCoordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma
Anatomic Pathology / CYTOKERATINS 7 AND 20 IN PROSTATE AND BLADDER CARCINOMAS Coordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma Nader H. Bassily,
More informationMicrocystic transitional cell carcinoma: a rare tumor of the urinary bladder
PATHOLOGICA 2017;109:151-155 Case report Microcystic transitional cell carcinoma: a rare tumor of the urinary bladder M. TRIKI 1, L. AYADI 1, R. KALLEL 1, S. CHARFI 1, I. SAGUEM 1, N. MHIRI 2, T.S. BOUDAWARA
More informationBLADDER CANCER EPIDEMIOLOGY
BLADDER CANCER WHAT IS NEW AND CLINICALLY RELEVANT Canadian Geese - Geist Reservoir (my backyard), Indianapolis, USA BLADDER CANCER EPIDEMIOLOGY Urinary bladder 17,960 2% Urinary bladder 4,390 1.6% Siegel
More informationPresentation material is for education purposes only. All rights reserved URMC Radiology Page 1 of 98
Presentation material is for education purposes only. All rights reserved. 2011 URMC Radiology Page 1 of 98 Radiology / Pathology Conference February 2011 Brooke Koltz, Cytopathology Resident Presentation
More informationNormal Morphology. Anatomic Considerations. Normal Urothelial Histology and Cytology
1 Normal Morphology Anatomic Considerations The urinary tract can be divided into three regions: the kidney; the calyces, pelves and ureters (upper collecting system or upper tract); and the bladder and
More informationMucin-producing urothelial-type adenocarcinoma of prostate: report of two cases of a rare and diagnostically challenging entity
& 2005 USCAP, Inc All rights reserved 0893-3952/05 $30.00 www.modernpathology.org Mucin-producing urothelial-type adenocarcinoma of prostate: report of two cases of a rare and diagnostically challenging
More informationA 53 year-old woman with a lung mass, right hilar mass and mediastinal adenopathy.
November 2015 Case of the Month A 53 year-old woman with a lung mass, right hilar mass and mediastinal adenopathy. Contributed by: Rasha Salama, M.D., IU Department of Pathology and Laboratory Medicine
More informationPSA. HMCK, p63, Racemase. HMCK, p63, Racemase
Case 1 67 year old male presented with gross hematuria H/o acute prostatitis & BPH Urethroscopy: small, polypoid growth with a broad base emanating from the left side of the verumontanum Serum PSA :7 ng/ml
More informationARTHUR PURDY STOUT SOCIETY COMPANION MEETING: DIFFICULT NEW DIFFERENTIAL DIAGNOSES IN PROSTATE PATHOLOGY. Jonathan I. Epstein.
1 ARTHUR PURDY STOUT SOCIETY COMPANION MEETING: DIFFICULT NEW DIFFERENTIAL DIAGNOSES IN PROSTATE PATHOLOGY Jonathan I. Epstein Professor Pathology, Urology, Oncology The Reinhard Professor of Urological
More informationIntraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance
& 2006 USCAP, Inc All rights reserved 0893-3952/06 $30.00 www.modernpathology.org Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance Charles C Guo 1 and
More informationCarcinoma of the Urinary Bladder Histopathology
Carcinoma of the Urinary Bladder Histopathology Reporting Proforma (Radical & Partial Cystectomy, Cystoprostatectomy) Includes the International Collaboration on Cancer reporting dataset denoted by * Family
More informationPapillary Lesions of the Breast A Practical Approach to Diagnosis. (Arch Pathol Lab Med. 2016;140: ; doi: /arpa.
Papillary Lesions of the Breast A Practical Approach to Diagnosis (Arch Pathol Lab Med. 2016;140:1052 1059; doi: 10.5858/arpa.2016-0219-RA) Papillary lesions of the breast Span the spectrum of benign,
More information4/12/2018. MUSC Pathology Symposium Kiawah Island April 18, Jesse K. McKenney, MD
MUSC Pathology Symposium Kiawah Island April 18, 2018 Jesse K. McKenney, MD 1 Urothelial Carcinoma with Alternative Differentiation 2 Urothelial Carcinoma with Alternative Differentiation Recognition as
More informationScience & Technologies ATYPICAL NEPHROGENIC METAPLASIA OF THE URINARY BLADDER: A CASE REPORT AND REVIEW OF THE LITERATURE
ATYPICAL NEPHROGENIC METAPLASIA OF THE URINARY BLADDER: A CASE REPORT AND REVIEW OF THE LITERATURE Vesela Ivanova *, Milen Karaivanov ** * Department of General and Clinical Pathology, Medical Faculty,
More information2016 WHO CLASSIFICATION OF TUMOURS OF THE PROSTATE. Peter A. Humphrey, MD, PhD Yale University School of Medicine New Haven, CT
2016 WHO CLASSIFICATION OF TUMOURS OF THE PROSTATE Peter A. Humphrey, MD, PhD Yale University School of Medicine New Haven, CT 2016 WHO CLASSIFICATION OF TUMOURS OF THE PROSTATE AUTHORS : PROSTATE CHAPTER
More informationPrimary Adenocarcinoma of the Urinary Bladder. Differential Diagnosis and Clinical Relevance
Primary Adenocarcinoma of the Urinary Bladder Differential Diagnosis and Clinical Relevance Minghao Zhong, MD, PhD; Elizabeth Gersbach, MD; Stephen M. Rohan, MD; Ximing J. Yang, MD, PhD Context. Glandular
More informationA215- Urinary bladder cancer tissues
A215- Urinary bladder cancer tissues (formalin fixed) For research use only Specifications: No. of cases: 45 Tissue type: Urinary bladder cancer tissues No. of spots: 2 spots from each cancer case (90
More informationCondyloma Acuminatum. Mimics of Bladder Cancer. Squamous Papilloma. Squamous epithelium in bladder
Mimics of Bladder Cancer Murali Varma Cardiff, UK wptmv@cf.ac.uk Squamous epithelium in bladder Non-keratinising vaginal type mucosa common in trigone region in women Normal variant Sarajevo Nov 2013 Squamous
More informationProstatic ductal adenocarcinoma is a subtype of
ORIGINAL ARTICLE High-grade Prostatic Intraepithelial Neoplasialike Ductal Adenocarcinoma of the Prostate: A Clinicopathologic Study of 28 Cases Fabio Tavora, MD* and Jonathan I. Epstein, MD*w z Abstract:
More informationACCME/Disclosures. Case History 4/13/2016. USCAP GU Specialty Conference Case 3. Ann Arbor, MI
USCAP GU Specialty Conference Case 3 March 2016 L. Priya Kunju, M.D. University of Michigan Health System Ann Arbor, MI University of Michigan Health System ACCME/Disclosures The USCAP requires that anyone
More informationBladder Case 1 SURGICAL PATHOLOGY REPORT. Procedure: Cystoscopy, transurethral resection of bladder tumor (TURBT)
Bladder Case 1 February 17, 2007 Specimen (s) received: Bladder Tumor Pre-operative Diagnosis: Bladder Cancer Post operative Diagnosis: Bladder Cancer Procedure: Cystoscopy, transurethral resection of
More informationCase Report Clear Cell Adenocarcinoma of the Renal Pelvis in a Male Patient
Case Reports in Pathology Volume 2013, Article ID 494912, 4 pages http://dx.doi.org/10.1155/2013/494912 Case Report Clear Cell Adenocarcinoma of the Renal Pelvis in a Male Patient Sarawut Kongkarnka, 1
More informationGOBLET CELL CARCINOID. Hanlin L. Wang, MD, PhD University of California Los Angeles
GOBLET CELL CARCINOID Hanlin L. Wang, MD, PhD University of California Los Angeles Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to
More informationGOBLET CELL CARCINOID
GOBLET CELL CARCINOID Hanlin L. Wang, MD, PhD University of California Los Angeles Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to
More informationGross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of
Tiền liệt tuyến Tiền liệt tuyến Gross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of solid and microcystic areas.
More informationTHE DIFFICULT DIAGNOSIS IN THE URINARY BLADDER: A SELECTIVE CONSIDERATION, MULLERIAN AND MULLERIAN- LIKE CONDITIONS. Robert H. Young, M.D.
THE DIFFICULT DIAGNOSIS IN THE URINARY BLADDER: A SELECTIVE CONSIDERATION, MULLERIAN AND MULLERIAN- LIKE CONDITIONS Robert H. Young, M.D. Benign and malignant müllerian lesions Mullerian-like appearances
More informationACCME/Disclosures. Cribriform Lesions of the Prostate. Case
Cribriform Lesions of the Prostate Ming Zhou, MD, PhD Departments of Pathology and Urology New York University Langone Medical Center New York, NY Ming.Zhou@NYUMC.ORG ACCME/Disclosures The USCAP requires
More informationAmerican Journals of Cancer Case Reports. A Rare Case of Rectal Metastasis from Sarcomatoid Variant of Urothelial Carcinoma: A Case Report
American Journals of Cancer Case Reports Lin JYJ et al. American Journals of Cancer Case Reports 2014, 3:1-5 http://ivyunion.org/index.php/ajccr Page 1 of 5 Vol 3 Article ID 20140539, 5 pages Case Report
More informationPlasmacytoid Variant Urothelial Carcinoma: Diagnostic and Grossing Challenges. Kailyn Gibson MS, PA-ASCP, Congli Wang, MD
1 Plasmacytoid Variant Urothelial Carcinoma: Diagnostic and Grossing Challenges Kailyn Gibson MS, PA-ASCP, Congli Wang, MD Johns Hopkins Hospital Department of Surgical Pathology 2 Plasmacytoid Variant
More informationProstate Immunohistochemistry. Literature Interpretation: Caveats. Must be aware of staining pattern of antibody in the relevant tissue
IHC Interpretation: General Principles (1) Prostate Immunohistochemistry Murali Varma Cardiff, UK wptmv@cf.ac.uk Sarajevo Nov 2013 Must be aware of staining pattern of antibody in the relevant tissue Nuclear/cytoplasmic/membranous
More informationNote: The cause of testicular neoplasms remains unknown
- In the 15- to 34-year-old age group, they are the most common tumors of men. - Tumors of the testis are a heterogeneous group of neoplasms that include: I. Germ cell tumors : 95%; all are malignant.
More informationCase Report Primary Signet-Ring Cell Adenocarcinoma of the Urinary Bladder Treated with Partial Cystectomy: A Case Report and Review of the Literature
Hindawi Case Reports in Urology Volume 2017, Article ID 6829692, 4 pages https://doi.org/10.1155/2017/6829692 Case Report Primary Signet-Ring Cell Adenocarcinoma of the Urinary Bladder Treated with Partial
More informationDiplomate of the American Board of Pathology in Anatomic and Clinical Pathology
A 33-year-old male with a left lower leg mass. Contributed by Shaoxiong Chen, MD, PhD Assistant Professor Indiana University School of Medicine/ IU Health Partners Department of Pathology and Laboratory
More informationPROSTATIC ADENOCARCINOMA: DIAGNOSTIC CRITERIA AND IMPORTANT MIMICKERS PROSTATIC ADENOCARCINOMA: DIAGNOSTIC CRITERIA
PROSTATIC ADENOCARCINOMA: DIAGNOSTIC CRITERIA AND IMPORTANT MIMICKERS PROSTATIC ADENOCARCINOMA: DIAGNOSTIC CRITERIA 1 A good H & E helps! ADENOCARCINOMA DIAGNOSTIC CRITERIA Relatively uniform proliferation
More informationMammary analogue secretory carcinoma of salivary gland A case report of new entity
Case Report Mammary analogue secretory carcinoma of salivary gland A case report of new entity Vaibhav Bhika Bari 1*, Sandhya Unmesh Bholay 2 1 Assistant Professor, 2 Associate Professor Rajiv Gandhi Medical
More informationThey Do Look Alike : Mimics of Prostate Cancer in Biopsy Samples
They Do Look Alike : in Biopsy Samples Gladell P. Paner, MD Departments of Pathology and Surgery (Urology) University of Chicago, IL USA Gladell.paner@uchospitals.edu Benign in Needle Biopsy 1. Benign
More informationProstate Pathology: Prostate Carcinoma, variants and Gleason Grading (Part 1)
Prostate Pathology: Prostate Carcinoma, variants and Gleason Grading (Part 1) Jae Y. Ro, MD, PhD June 7, 2012 Ten Leading Cancer Types for the Estimated New Cancer Cases and Deaths By Sex, United States,
More informationMetachronous anterior urethral metastasis of prostatic ductal adenocarcinoma
http://dx.doi.org/10.7180/kmj.2016.31.1.66 KMJ Case Report Metachronous anterior urethral metastasis of prostatic ductal adenocarcinoma Jeong Hyun Oh 1, Taek Sang Kim 1, Hyun Yul Rhew 1, Bong Kwon Chun
More informationCase: The patient is a 62 year old woman with a history of renal cell carcinoma that was removed years ago. A 2.4 cm liver mass was found on CT
Case: The patient is a 62 year old woman with a history of renal cell carcinoma that was removed years ago. A 2.4 cm liver mass was found on CT during follow- up. ALT, AST, Alk Phos and bilirubin were
More informationSalivary Glands 3/7/2017
Salivary Glands 3/7/2017 Goals and objectives Focus on the entities unique to H&N Common board type facts Information for your future practice Salivary Glands Salivary Glands Major gland. Paratid. Submandibular.
More informationPathology of the Prostate. PathoBasic Tatjana Vlajnic
Pathology of the Prostate PathoBasic 24.01.17 Tatjana Vlajnic Overview Adenocarcinoma of the prostate Grading Special variants Mimickers of prostate adenocarcinoma Atrophy Inflammatory conditions Granulomatous
More informationUniversity Journal of Pre and Para Clinical Sciences
ISSN 2455 2879 Volume 2 Issue 1 2016 Metaplastic carcinoma breast a rare case report Abstract : Metaplastic carcinoma of the breast is a rare malignancy with two distinct cell lines described as a breast
More informationMacro- and microacinar proliferations of the prostate
Macro- and microacinar proliferations of the prostate (with emphasis on cancer mimics) Rodolfo Montironi, MD (IT), FRCPath (UK), IFCAP (USA) Polytechnic University of Marche Region (Ancona) School of Medicine,
More informationObjectives. Atypical Glandular Cells. Atypical Endocervical Cells. Reactive Endocervical Cells
2013 California Society of Pathologists 66 th Annual Meeting San Francisco, CA Atypical Glandular Cells to Early Invasive Adenocarcinoma: Cervical Cytology and Histology Christina S. Kong, MD Associate
More informationUpdate on Bladder Cancer: What s New in the 2016 WHO Classification of Bladder Tumors and 8 th Edition of AJCC Staging Manual
Update on Bladder Cancer: What s New in the 2016 WHO Classification of Bladder Tumors and 8 th Edition of AJCC Staging Manual Rajal B. Shah, M.D. Director, Urologic Pathology SHAHR6@ccf.org @rajalbshah
More informationINTRADUCTAL LESIONS OF THE PROSTATE. Jonathan I. Epstein
INTRADUCTAL LESIONS OF THE PROSTATE Jonathan I. Epstein Topics Prostatic intraepithelial neoplasia (PIN) Intraductal adenocarcinoma (IDC-P) Intraductal urothelial carcinoma Ductal adenocarcinoma High Prostatic
More informationCase Report Urachal Tumor: A Case Report of an Extremely Rare Carcinoma
Hindawi Case Reports in Pathology Volume 2017, Article ID 1942595, 5 pages https://doi.org/10.1155/2017/1942595 Case Report Urachal Tumor: A Case Report of an Extremely Rare Carcinoma José Palla Garcia,
More informationROLE OF PROSTATIC BASAL CELL MARKER IN DIAGNOSIS OF PROSTATIC LESIONS
Original Research Article Pathology International Journal of Pharma and Bio Sciences ISSN 0975-6299 ROLE OF PROSTATIC BASAL CELL MARKER IN DIAGNOSIS OF PROSTATIC LESIONS SUBATHRA K* Department of pathology,
More informationEpithelial tumors. Dr. F.F. Khuzin, PhD Dr. M.O. Mavlikeev
Epithelial tumors Dr. F.F. Khuzin, PhD Dr. M.O. Mavlikeev Epithelial tumors Tumors from the epithelium are the most frequent among tumors. There are 2 group features of these tumors: The presence in most
More informationCase history: Figure 1. H&E, 5x. Figure 2. H&E, 20x.
1 Case history: A 49 year-old female presented with a 5 year history of chronic anal fissure. The patient s past medical history is otherwise unremarkable. On digital rectal examination there was a very
More informationAlthough partial atrophy is one of the most common
ORIGINAL ARTICLE Partial Atrophy on Prostate Needle Biopsy Cores: A Morphologic and Immunohistochemical Study Wenle Wang, MD, PhD,* Xinlai Sun, MD,w and Jonathan I. Epstein, MD*zy Abstract: Partial atrophy
More informationMody. AIS vs. Invasive Adenocarcinoma of the Cervix
Common Problems in Gynecologic Pathology Michael T. Deavers, M.D. Houston Methodist Hospital, Houston, Texas Common Problems in Gynecologic Pathology Adenocarcinoma in-situ (AIS) of the Cervix vs. Invasive
More informationLow grade urothelial carcinoma mimicking basal cell hyperplasia and transitional metaplasia in needle prostate biopsy
ORIGINAL ARTICLE Vol. 42 (2): 247-252, March - April, 2016 doi: 10.1590/S1677-5538.IBJU.2014.0512 Low grade urothelial carcinoma mimicking basal cell hyperplasia and transitional metaplasia in needle prostate
More informationJesse K. McKenney, MD
Jesse K. McKenney, MD Outline Microscopic anatomy of the urinary bladder Diagnosing invasion Subtle patterns (variants) of carcinoma Clinically important variants of carcinoma Microanatomy of Bladder Initial
More information1 NORMAL HISTOLOGY AND METAPLASIAS
1 NORMAL HISTOLOGY AND METAPLASIAS, MD Anatomy and Histology 1 Metaplasias 2 ANATOMY AND HISTOLOGY The female breast is composed of a branching duct system, which begins at the nipple with the major lactiferous
More informationWendy L Frankel. Chair and Distinguished Professor
1 Wendy L Frankel Chair and Distinguished Professor Case 1 59 y/o woman Abdominal pain No personal or family history of cancer History of colon polyps Colonoscopy Polypoid rectosigmoid mass Biopsy 3 4
More informationUpdate in Salivary Gland Pathology. Benjamin L. Witt University of Utah/ARUP Laboratories February 9, 2016
Update in Salivary Gland Pathology Benjamin L. Witt University of Utah/ARUP Laboratories February 9, 2016 Objectives Review the different appearances of a selection of salivary gland tumor types Establish
More informationDisclosure. Relevant Financial Relationship(s) None. Off Label Usage None MFMER slide-1
Disclosure Relevant Financial Relationship(s) None Off Label Usage None 2013 MFMER slide-1 Case Presentation A 43 year old male, with partial nephrectomy for a right kidney mass 2013 MFMER slide-2 2013
More informationUnusual Variants of Bladder Cancer Cristina Magi-Galluzzi, MD, PhD
Unusual Variants of Bladder Cancer Cristina Magi-Galluzzi, MD, PhD Director of Genitourinary Pathology, Professor of Pathology, Lerner College of Medicine Cleveland Clinic Objectives Update on variants
More informationAlthough current American Cancer Society guidelines
ORIGINAL ARTICLE Diffuse Adenosis of the Peripheral Zone in Prostate Needle Biopsy and Prostatectomy Specimens Tamara L. Lotan, MD* and Jonathan I. Epstein, MD*w z Abstract: We have observed a group of
More information6/3/2010. Outline of Talk. Lobular Breast Cancer: Definition of lobular differentiation. Common Problems in Diagnosing LCIS in Core Biopsies
Outline of Talk Lobular Breast Cancer: Common Problems in Diagnosing LCIS in Core Biopsies Definition of lobular differentiation Variants of LCIS that: carry risk for unsampled invasive cancer mimic DCIS
More informationImmunohistochemistry and Bladder Tumours
Immunohistochemistry and Bladder Tumours Dr. Andrew J. Evans MD PhD FRCPC Consultant in Genitourinary Pathology University Health Network Toronto, ON Objec ves Review markers of urothelial differen a on
More informationHow to Recognize Gynecologic Cancer Cells from Pelvic Washing and Ascetic Specimens
How to Recognize Gynecologic Cancer Cells from Pelvic Washing and Ascetic Specimens Wenxin Zheng, M.D. Professor of Pathology and Gynecology University of Arizona zhengw@email.arizona.edu http://www.zheng.gynpath.medicine.arizona.edu/index.html
More informationDIAGNOSTIC SLIDE SEMINAR: PART 1 RENAL TUMOUR BIOPSY CASES
DIAGNOSTIC SLIDE SEMINAR: PART 1 RENAL TUMOUR BIOPSY CASES Dr. Andrew J. Evans MD, PhD, FACP, FRCPC Consultant in Genitourinary Pathology University Health Network, Toronto, ON Case 1 43 year-old female,
More informationUrinary Bladder, Ureter, and Renal Pelvis
Urinary Bladder, Ureter, and Renal Pelvis Protocol applies to all carcinomas of the urinary bladder, ureter, and renal pelvis. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6th edition Procedures
More informationPrimary enteric adenocarcinoma with predominantly signet ring features of the lung: A case report with clinicopathological and molecular findings
CASE REPORT Primary enteric adenocarcinoma with predominantly signet ring features of the lung: A case report with clinicopathological and molecular findings Makoto Nagashima 1, Ayako Moriyama 1, Yasuo
More informationDiseases of the breast (1 of 2)
Diseases of the breast (1 of 2) Introduction A histology introduction Normal ducts and lobules of the breast are lined by two layers of cells a layer of luminal cells overlying a second layer of myoepithelial
More informationLesions Mimicking Adenoid Cystic Carcinoma. Diagnostic Problems in Salivary Gland Pathology An Update 5/29/2009
Diagnostic Problems in Salivary Gland Pathology An Update Lesions Mimicking Adenoid Cystic Carcinoma Stacey E. Mills, M.D. W.S. Royster Professor of Pathology Director of Surgical and Cytopathology University
More informationCASE 4 21/07/2017. Ectopic Prostatic Tissue in Cervix. Female 31. LLETZ for borderline nuclear abnormalities
Female 31 CASE 4 LLETZ for borderline nuclear abnormalities PSA Ectopic Prostatic Tissue in Cervix AJSP 2006;30;209-215 usually incidental microscopic finding usually in ectocervical stroma? developmental
More informationPRIMARY SIGNET RING CELL CARCINOMA OF URINARY BLADDER A RARE CASE WITH RARE PRESENTATION
PRIMARY SIGNET RING CELL CARCINOMA OF URINARY BLADDER A RARE CASE WITH RARE PRESENTATION *R. Sharma 1, A. Sharma 1, N. Ledwani 2 and A. Maurya 1 1 Department of Pathology and 2 Department of Oncosurgery,
More informationIndex 179. Genital tract contaminants, 17, 20, 22, 150 papilloma virus-infected cells, 47 squamous cells, sources of, 7
Index Accuracy of urinary cytology, 166 Acute inflammatory cells, 38 catheter sample, 39 herpes simplex infections, 44 carcinomas, 104, 105 non-viral inclusions, 52, 53 voided urine, 17 Adenocarcinoma
More informationPathological Classification of Hepatocellular Carcinoma
3 rd APASL Single Topic Conference: HCC in 3D Pathological Classification of Hepatocellular Carcinoma Glenda Lyn Y. Pua, M.D. HCC Primary liver cancer is the 2 nd most common cancer in Asia HCC is the
More information3/27/2017. Pulmonary Pathology Specialty Conference. Disclosure of Relevant Financial Relationships. Clinical History:
Pulmonary Pathology Specialty Conference Saul Suster, M.D. Medical College of Wisconsin Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position
More informationGUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER
GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER (Limited text update December 21) M. Babjuk, W. Oosterlinck, R. Sylvester, E. Kaasinen, A. Böhle, J. Palou, M. Rouprêt Eur Urol 211 Apr;59(4):584-94 Introduction
More informationPitfalls in thyroid tumor pathology. Prof.Valdi Pešutić-Pisac MD, PhD
Pitfalls in thyroid tumor pathology Prof.Valdi Pešutić-Pisac MD, PhD Too many or... Tumour herniation through a torn capsule simulating capsular invasion fibrous capsule with a sharp discontinuity, suggestive
More informationCase 18. M75. Excision of mass on scalp. Clinically SCC. The best diagnosis is:
Case 18 M75. Excision of mass on scalp. Clinically SCC. The best diagnosis is: A. Pilomatrical carcinoma B. Adnexal carcinoma NOS C. Metastatic squamous cell carcinoma D.Primary squamous cell carcinoma
More informationDIAGNOSTIC DILEMMA. Case Reports Clinical history. Materials and Methods
DIAGNOSTIC DILEMMA A Metastatic Renal Carcinoid Tumor Presenting as Breast Mass: A Diagnostic Dilemma Farnaz Hasteh, M.D., 1 Robert Pu, M.D., Ph.D., 2 and Claire W. Michael, M.D. 2 * We present clinicopathological
More informationWhen Immunostains Can Get You in Trouble: Gynecologic Pathology p16: Panacea or Pandora s Box?
When Immunostains Can Get You in Trouble: Gynecologic Pathology p16: Panacea or Pandora s Box? Teri A. Longacre, MD Stanford Medicine Stanford California pi6 in Gynecologic Pathology: Panacea or Pandora
More informationBiliary tract tumors
Short Course 2010 Annual Fall Meeting of the Korean Society for Pathologists Biliary tract tumors Joon Hyuk Choi, M.D., Ph.D. Professor, Department of Pathology, Yeungnam Univ. College of Medicine, Daegu,
More informationTumors of kidney and urinary bladder
Tumors of kidney and urinary bladder Overview of kidney tumors Benign and malignant Of the benign: papillary adenoma -cortical -small (0.5cm) -in 40% of population -clinically insignificant The most common
More informationCase 2. Dr. Sathima Natarajan M.D. Kaiser Permanente Medical Center Sunset
Case 2 Dr. Sathima Natarajan M.D. Kaiser Permanente Medical Center Sunset History 24 year old male presented with a 3 day history of right flank pain, sharp in nature Denies fever, chills, hematuria or
More informationPathology of bladder cancer in Egypt; a current study.
Pathology of bladder cancer in Egypt; a current study. Thesis Submitted for partial fulfillment of Master degree in urology By Mohamed Atef Mohamed Ahmed M.B.B.CH Supervised by Prof.Dr.: Omar Mohamed Abdel-
More informationPapillary adenocarcinoma of the rete testis with adjacent hyperplasia: a case report
CASE REPORT Papillary adenocarcinoma of the rete testis with adjacent hyperplasia: a case report Carolina Polanco 1, Cooley G. Pantazis 2, Rolando Prieto 2, Kenneth A. Iczkowski 1 1. Medical College of
More informationPrimary signet-ring cell adenocarcinoma of the urinary bladder treated with partial
1 P a g e Primary signet-ring cell adenocarcinoma of the urinary bladder treated with partial cystectomy: a case report and review of literature Umesh Jayarajah, Email: umeshe.jaya@gmail.com Department
More informationProstate cancer ~ diagnosis and impact of pathology on prognosis ESMO 2017
Prostate cancer ~ diagnosis and impact of pathology on prognosis ESMO 2017 Dr Puay Hoon Tan Division of Pathology Singapore General Hospital Prostate cancer (acinar adenocarcinoma) Invasive carcinoma composed
More informationInternational Society of Gynecological Pathologists Symposium 2007
International Society of Gynecological Pathologists Symposium 2007 Anais Malpica, M.D. Department of Pathology The University of Texas M.D. Anderson Cancer Center Grading of Ovarian Cancer Histologic grade
More informationHONDA, Nobuaki; YAMADA, Yoshiaki; N.
Title Mesonephric adenocarcinoma of the u report HONDA, Nobuaki; YAMADA, Yoshiaki; N Author(s) Hiroshi; FUKATSU, Hidetoshi; NONOMU HATANO, Yukio Citation 泌尿器科紀要 (2000), 46(1): 27-31 Issue Date 2000-01
More informationCancers of unknown primary : Knowing the unknown. Prof. Ahmed Hossain Professor of Medicine SSMC
Cancers of unknown primary : Knowing the unknown Prof. Ahmed Hossain Professor of Medicine SSMC Definition Cancers of unknown primary site (CUPs) Represent a heterogeneous group of metastatic tumours,
More information04/10/2018. Intraductal Papillary Neoplasms Of Breast INTRADUCTAL PAPILLOMA
Intraductal Papillary Neoplasms Of Breast Savitri Krishnamurthy MD Professor of Pathology Deputy Division Head The University of Texas MD Anderson Cancer Center 25 th Annual Seminar in Pathology Pittsburgh,
More information2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a Pseudocapsule
GENITOURINARY PATHOLOGY Kathleen M. O Toole, M.D. Renal Cell Carcinoma 2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow Necrotic Mass Grossly is a Bright
More informationBasement membrane in lobule.
Bahram Memar, MD Basement membrane in lobule. Normal lobule-luteal phase Normal lobule-follicular phase Lactating breast Greater than 95% are adenocarcinomas in situ carcinomas and invasive carcinomas.
More informationAdenocarcinoma of the Cervix
Question 1. Each of the following statements about cervical adenocarcinoma is true except: Adenocarcinoma of the Cervix SAMS a) A majority of women with cervical adenocarcinoma have stage I tumors at diagnosis.
More information3/28/2017. Disclosure of Relevant Financial Relationships. GU Evening Subspecialty Case Conference. Differential Diagnosis:
GU Evening Subspecialty Case Conference Rajal B. Shah, M.D. VP, Medical Director, Urologic Pathology Miraca Life Sciences, Irving, Texas Clinical Associate Professor of Pathology Baylor College of Medicine,
More informationDiagnostic accuracy of percutaneous renal tumor biopsy May 10 th 2018
Diagnostic accuracy of percutaneous renal tumor biopsy May 10 th 2018 Dr. Tzahi Neuman Dep.Of Pathology Hadassah Medical Center Jerusalem, Israel, (tneuman@hadassah.org.il) Disclosure: 1 no conflicts of
More informationSarcomatoid (spindle cell) carcinoma of the cricopharynx presenting as dysphagia
Case Report Sarcomatoid (spindle cell) carcinoma of the cricopharynx presenting as dysphagia Jagtap Sunil V. 1, Shukla Dhirajkumar B. 2, Jagtap Swati S. 3, Havle Abhay D. 4 1 Associate Professor, Department
More informationInt J Clin Exp Pathol 2015;8(3): /ISSN: /IJCEP Shogo Tajima 1, Kenji Koda 2
Int J Clin Exp Pathol 2015;8(3):3288-3293 www.ijcep.com /ISSN:1936-2625/IJCEP0005608 Case Report Transition between urothelial carcinoma in situ and non-invasive micropapillary carcinoma as a pivot connection
More information